CoChat

Loss of Protein Stability and Function Caused by P228L Variation in NADPH-Cytochrome P450 Reductase Linked to Lower Testosterone Levels

Open access
Rojas Velazquez, Maria Natalia, Noebauer, Mathias, Pandey, Amit V. · 2022 · International Journal of Molecular Sciences

Published version of a preprint

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index; 11 of the 27 sources its claims cite were checked for support.

Abstract

Cytochrome P450 oxidoreductase (POR) is the redox partner of steroid and drug-metabolising cytochromes P450 located in the endoplasmic reticulum. Mutations in POR cause a broad range of metabolic disorders. The POR variant rs17853284 (P228L), identified by genome sequencing, has been linked to lower testosterone levels and reduced P450 activities. We expressed the POR wild type and the P228L variant in bacteria, purified the proteins, and performed protein stability and catalytic functional studies. Variant P228L affected the stability of the protein as evidenced by lower unfolding temperatures and higher sensitivity to urea denaturation. A significant decline in the rate of electron transfer to cytochrome c and thiazolyl blue tetrazolium (MTT) was observed with POR P228L, while activities of CYP3A4 were reduced by 25% and activities of CYP3A5 and CYP2C9 were reduced by more than 40% compared with WT POR. The 17,20 lyase activity of CYP17A1, responsible for the production of the main androgen precursor dehydroepiandrosterone, was reduced to 27% of WT in the presence of the P228L variant of POR. Based on in silico and in vitro studies, we predict that the change of proline to leucine may change the rigidity of the protein, causing conformational changes in POR, leading to altered electron transfer to redox partners. A single amino acid change can affect protein stability and cause a severe reduction in POR activity. Molecular characterisation of individual POR mutations is crucial for a better understanding of the impact on different redox partners of POR.

Overview

CoChat Summary

TL;DR

The POR variant P228L (rs17853284) is rare, highly conserved, and destabilizes the protein, reducing electron transfer and multiple P450 activities, including CYP17A1 17,20 lyase to 27% of WT. These effects provide a mechanism for the variant’s association with lower testosterone levels and suggest it may contribute to P450 oxidoreductase deficiency when combined with a severe second-allele POR variant.

Key findings

  • P228L is a rare POR variant: allele frequency T = 0.00104–0.00346 across databases (~0.2% of sequenced alleles); GnomAD frequencies were 0.004702 in Europeans, 0.001057 in African/African Americans, 0.0007576 in Latino/Admixed Americans, 0.0001282 in South Asians, and absent in East Asians.
  • P228L reduced flavin content to FMN 79% and FAD 82% of WT, and destabilized POR: the variant was degraded even at 4 °C, completely degraded around 45 °C, while WT POR was still detectable at 52 °C.
  • P228L severely decreased model electron acceptor reduction: cytochrome c reduction lost 74% of activity, and MTT reduction decreased by >90% with lower substrate affinity.
  • P450 activities supported by P228L were reduced: CYP2C9 to 51.5% of WT, CYP3A5 to 41% of WT, CYP3A4 reduced by 25%, CYP17A1 17α-hydroxylase to 57% of WT, CYP17A1 17,20 lyase to 27% of WT, and CYP19A1 showed a 54% reduction.

Methods

  • Allele frequencies were extracted from GnomAD_exome/GnomAD, ALFA, ExAC, PAGE_STUDY, GO-ESP, and 1000 Genomes; conservation was assessed by ConSurf using 250 POR homologs.
  • In silico impact was predicted with PredictSNP2, CADD, DANN, FTHMM, FunSeq2, GWAVA, Meta-SNP, and DynaMut-2.0.
  • Recombinant WT and P228L POR were expressed in E. coli BL21(DE3), purified by IMAC, and analyzed by flavin content, FASTpp thermolysin proteolysis, CPM fluorescence, cytochrome c/MTT reduction kinetics, CYP3A4/CYP3A5/CYP2C9 assays with BOMCC in reconstituted liposomes, and CYP17A1/CYP19A1 assays as previously described; data are mean ± SEM.

Limitations

  • The paper does not state a formal limitations section.
  • Evident from the text: P228L was characterized in recombinant E. coli/purified systems and in silico predictions, not in patient cells or clinical cohorts; the variant is found in healthy individuals and has conflicting pathogenicity interpretations.
  • Evident from the text: the conclusion that rs17853284 is disease-causing and prominent with a severe second-allele POR variant is proposed/suggested rather than directly demonstrated in this study.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/ijms231710141

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 POR is a key enzyme in several metabolic processes, such as drug metabolism, steroid biosynthesis, and sterol and retinoic acid metabolism. POR provides the necessary equivalents from NADPH to its multiple redox partners to accomplish their functions.
Figure 1 POR is a key enzyme in several metabolic processes, such as drug metabolism, steroid biosynthesis, and sterol and retinoic acid metabolism. POR provides the necessary equivalents from NADPH to its multiple redox partners to accomplish their functions.CC BY · PubMed Central
Figure 2 Population distribution of POR variant P228L extracted from GnomAD database (variant ID: 7-75610876-C-T). P228L appears to be a rare variant mainly found in Europeans (EUR). The allele frequency is similar in African/African Americans (AFR) and Latino/Admixed Americans (AMR). The frequency is lower in South Asians and P228L has not been found in East Asians (EAS).
Figure 2 Population distribution of POR variant P228L extracted from GnomAD database (variant ID: 7-75610876-C-T). P228L appears to be a rare variant mainly found in Europeans (EUR). The allele frequency is similar in African/African Americans (AFR) and Latino/Admixed Americans (AMR). The frequency is lower in South Asians and P228L has not been found in East Asians (EAS).CC BY · PubMed Central
Figure 3 ConSurf analysis of POR (PDB # 5FA6) evolutionary conservation profile. (A) A segment (residues 210–258) of the multiple-sequence alignment of 250 POR homologues across species. Position 228 is indicated with an arrow; the P228 has a score of 9 being classified as highly conserved. The alignment is coloured according to the ConSurf conservation colour bar (details below). (B) POR structure is illustrated as a surface model; the amino acids are coloured according to the conservation scores. The colour bar varies from (1) cyan, meaning variable, to (9) maroon, meaning conserved. The amino acids coloured yellow have not been classified due to insufficient data.
Figure 3 ConSurf analysis of POR (PDB # 5FA6) evolutionary conservation profile. (A) A segment (residues 210–258) of the multiple-sequence alignment of 250 POR homologues across species. Position 228 is indicated with an arrow; the P228 has a score of 9 being classified as highly conserved. The alignment is coloured according to the ConSurf conservation colour bar (details below). (B) POR structure is illustrated as a surface model; the amino acids are coloured according to the conservation scores. The colour bar varies from (1) cyan, meaning variable, to (9) maroon, meaning conserved. The amino acids coloured yellow have not been classified due to insufficient data.CC BY · PubMed Central
Figure 4 Visual representation of the vibrational entropy difference (ΔΔS) between POR wild type and P228L structures (ΔΔSVib: −0.904 kcal·mol−1.K−1) calculated with ENCoM (A). (B) Mutant P228L decreased the flexibility of the molecule. Amino acids are coloured according to the vibrational entropy change upon mutation. Blue represents a rigidification of the structure and red represents a gain in flexibility.
Figure 4 Visual representation of the vibrational entropy difference (ΔΔS) between POR wild type and P228L structures (ΔΔSVib: −0.904 kcal·mol−1.K−1) calculated with ENCoM (A). (B) Mutant P228L decreased the flexibility of the molecule. Amino acids are coloured according to the vibrational entropy change upon mutation. Blue represents a rigidification of the structure and red represents a gain in flexibility.CC BY · PubMed Central
Figure 5 Flavin content and stability of WT and P228L POR. The fluorescence of released FMN/FAD was measured with excitation at 450 nm and emission at 535 nm. (A) FMN content and (B) FAD content of POR WT and P228L are shown. (C) POR structure is illustrated showing the cysteine residues inside or on the surface of the folded protein coloured in yellow. (D) Stability analysis of WT and P228L by CPM fluorescence assay. The stability of protein structure was tested by exposure to increasing concentration of urea. The fluorescence emission at 463 nm increased upon unfolding due to increased access of CPM molecules to hidden cysteine residues in the unfolded protein. The P228L mutant of POR was less stable, the P228L unfolded at a lower concentration of urea, and the flavin content was lower than WT POR. (E) Analysis of WT and P228L stability by FASTpp assay. FASTpp of WT and P228L were analyzed by Western blot as described in the methods. Original western blot images are provided in Supplementary Materials as Supplementary Figures S1–S4. (F) Representative melting curve of WT (Tm 51.7 °C) and P228L (Tm 44.4 °C). The P228L mutant of POR was less stable than the WT POR protein and was degraded faster and at lower temperatures upon thermolysin treatment.
Figure 5 Flavin content and stability of WT and P228L POR. The fluorescence of released FMN/FAD was measured with excitation at 450 nm and emission at 535 nm. (A) FMN content and (B) FAD content of POR WT and P228L are shown. (C) POR structure is illustrated showing the cysteine residues inside or on the surface of the folded protein coloured in yellow. (D) Stability analysis of WT and P228L by CPM fluorescence assay. The stability of protein structure was tested by exposure to increasing concentration of urea. The fluorescence emission at 463 nm increased upon unfolding due to increased access of CPM molecules to hidden cysteine residues in the unfolded protein. The P228L mutant of POR was less stable, the P228L unfolded at a lower concentration of urea, and the flavin content was lower than WT POR. (E) Analysis of WT and P228L stability by FASTpp assay. FASTpp of WT and P228L were analyzed by Western blot as described in the methods. Original western blot images are provided in Supplementary Materials as Supplementary Figures S1–S4. (F) Representative melting curve of WT (Tm 51.7 °C) and P228L (Tm 44.4 °C). The P228L mutant of POR was less stable than the WT POR protein and was degraded faster and at lower temperatures upon thermolysin treatment.CC BY · PubMed Central
Figure 6 Reduction kinetics of model electron acceptors by WT (black dot)and P228L (inverted triangle) POR. (A) Cytochrome c reduction assays by WT and P228L POR. (B) MTT Reduction assay with WT and L374H variant of POR. The curves represent the best nonlinear fits to the Michaelis–Menten equation.
Figure 6 Reduction kinetics of model electron acceptors by WT (black dot)and P228L (inverted triangle) POR. (A) Cytochrome c reduction assays by WT and P228L POR. (B) MTT Reduction assay with WT and L374H variant of POR. The curves represent the best nonlinear fits to the Michaelis–Menten equation.CC BY · PubMed Central
Figure 7 CYP3A4, CYP3A5, and CYP2C9 activity promoted by WT and P228L POR. Activity with the WT POR was set as a hundred percent, and results are shown as a percentage of WT activity. (A) In CYP3A4 assays, POR variant P228L had 79% of WT activity, while (B) in CYP3A5 assays, variant P228L had 41% of WT activity, and (C) in CYP2C9 assays, POR variant P228L had 52% of WT activity.
Figure 7 CYP3A4, CYP3A5, and CYP2C9 activity promoted by WT and P228L POR. Activity with the WT POR was set as a hundred percent, and results are shown as a percentage of WT activity. (A) In CYP3A4 assays, POR variant P228L had 79% of WT activity, while (B) in CYP3A5 assays, variant P228L had 41% of WT activity, and (C) in CYP2C9 assays, POR variant P228L had 52% of WT activity.CC BY · PubMed Central

Verification

Claims the paper makes

4 Valid · 1 Not valid · 5 Not checked · 33 Own results and interpretations

18 more claims

Create a free account to see all 43 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 6
  • It may state two separate claims as one. 15

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Cited by

See all 12

Metadata

Authors
Rojas Velazquez, M. N., Noebauer, M., & Pandey, A. V.
Affiliations
  • Pediatric Endocrinology Unit, Department of Pediatrics, University Children’s Hospital Bern, 3010 Bern, Switzerland
  • University of Bern (CH)
Corresponding author
Pandey, Amit V.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2022-09-04
Volume
23
Issue
17
Pages
10141
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4294733246
Cited by
11
References
50
Citations by year
2026: 1 · 2025: 5 · 2024: 4 · 2023: 1
FWCI
2.28
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • SWISS NATIONAL SCIENCE FOUNDATION (310030M_204518, 18A053, 2020.0557)
  • NOVARTIS FOUNDATION FOR MEDICAL-BIOLOGICAL RESEARCH (310030M_204518, 18A053, 2020.0557)
  • SWISS GOVERNMENT EXCELLENCE SCHOLARSHIP (ESKAS) (310030M_204518, 18A053, 2020.0557)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
Keywords
NADPH-cytochrome P450 reductase, androgen deficiency, protein stability, protein unfolding, urea denaturation, CYP3A4, CYP3A5, CYP2C9, steroid metabolism, dehydroepiandrosterone
MeSH terms
Mutation, NADPH-Ferrihemoprotein Reductase, Steroids, Testosterone, Protein Stability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.